Fate Therapeutics Inc

Ownership Transactions Reported by 19 Insiders

Symbol
FATE on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
12278 Scripps Summit Drive, San Diego, CA

Insiders trading volume in the past year

Fate Therapeutics Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Redmile Group, LLC Director, 10%+ Owner $79.1M +$166K +0.21% Jun 7, 2024
Bahram Valamehr Chief R&D Officer $4.01M -$49.4K -1.22% Jul 29, 2024
Cindy Tahl General Counsel and Secretary $3.82M -$106K -2.7% Jul 29, 2024
J. Scott Wolchko President and CEO, Director $2.99M -$62.9K -2.06% Feb 1, 2024
Edward J. Dulac III Chief Financial Officer $1.95M -$83.5K -4.11% Mar 4, 2024
Jerome Charles Bressi Exhibit 24 - Power of Attorney; Chief Regulatory and Quality Officer $1.17M Aug 14, 2024
Yu-Waye Chu Chief Medical Officer $615K Apr 18, 2023
Mark Plavsic Chief Technical Officer $541K Jan 10, 2023
Neelufar Mozaffarian Director $218K Jul 29, 2024
Brian Powl Chief Commercial Officer $180K Jul 5, 2023
Yuan Xu Director $146K -$2.68K -1.8% Aug 6, 2024
Robert Hershberg Director $109K Jun 6, 2023
John Mendlein Director $109K Jun 7, 2024
William H. Rastetter Director $109K Jun 7, 2024
Shefali Agarwal Director $109K Jun 7, 2024
Karin Jooss Director $109K Jun 7, 2024
Timothy Coughlin Director $109K Jun 7, 2024
Robert S. Epstein Director $109K Jun 7, 2024
Michael Lee Director $109K Jun 7, 2024

Recent Insider Transactions by Companies or Individuals for Fate Therapeutics Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.